Trial intelligence / Profile preview

Pretreated Magnesium in Liver Transplanted Patients

NCT00994981Phase 4Completed

Sponsor
The Catholic University of Korea
Start
Sep 2007
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of magnesium sulfate in reperfusion injury (IRI) (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Blood Lactate Level. Started Sep 2007; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT00994981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00994981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call